MedTrace Logo

Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee

NCT00790985 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 223

Last updated 2022-11-01

Study results available
· View outcomes & findings →

Summary

To compare flavocoxid with naproxen for patients with moderate to severe osteoarthritis of the knee.

Conditions

  • Osteoarthritis of Knee

Interventions

DIETARY_SUPPLEMENT

flavocoxid

medical food

DRUG

Naproxen

antiinflammatory drug

Sponsors & Collaborators

  • Primus Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Paul H Caldron, DO, FACP · AmeRuss Clinical Trials LLC, USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-08-31
Completion
2008-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00790985 on ClinicalTrials.gov